Suchergebnisse - "Landovitz, Raphael J"

PubPharm (193)

1

Trajectory of viral load in a prospective population-based cohort with incident SARS-CoV-2 G614 infection

enthalten in: bioRxiv.org | 2024

von Stankiewicz Karita, H. | Dong, T. | Johnston, C. | +23

2

HIV-1 Incidence, Adherence, and Drug Resistance in Individuals Taking Daily Emtricitabine/Tenofovir Disoproxil Fumarate for HIV-1 Pre-Exposure Prophylaxis : Pooled Analysis From 72 Global Studies

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2024

von Landovitz, R. | Tao, L. | Yang, J. | +60

3

Daily Oral HIV Pre-exposure Prophylaxis Among Young Men Who Have Sex With Men in the United States : Cost-saving at Generic Drug Price

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2024

von Amick, A. | Eskibozkurt, G. | Hosek, S. | +10

4

Efficacy and safety of long-acting cabotegravir compared with daily oral tenofovir disoproxil fumarate plus emtricitabine to prevent HIV infection in cisgender men and transgender women who have sex with men 1 year after study unblinding : a secondary analysis of the phase 2b and 3 HPTN 083 randomised controlled trial

enthalten in: The lancet. HIV | 2023

von Landovitz, R. | Hanscom, B. | Clement, M. | +28

CommentIn: Lancet HIV. 2023 Dec;10(12):e756-e757. - PMID 37952552

5

Efficacy, safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir for HIV pre-exposure prophylaxis in transgender women : a secondary analysis of the HPTN 083 trial

enthalten in: The lancet. HIV | 2023

von Marzinke, M. | Hanscom, B. | Wang, Z. | +71

CommentIn: Lancet HIV. 2023 Nov;10(11):e694-e695. - PMID 37783220

6

Prevention, treatment and cure of HIV infection

enthalten in: Nature reviews. Microbiology | 2023

von Landovitz, R. | Scott, H. | Deeks, S.

7

Breakthrough HIV-1 infection in setting of cabotegravir for HIV pre-exposure prophylaxis

enthalten in: AIDS (London, England) | 2023

von Hazra, A. | Landovitz, R. | Marzinke, M. | +2

8

Development and validation of a liquid chromatographic-tandem mass spectrometric assay for the quantification of cabotegravir and rilpivirine from dried blood spots

enthalten in: Journal of pharmaceutical and biomedical analysis | 2023

von Weld, E. | Parsons, T. | Gollings, R. | +4

9

Novel Approaches to Postnatal Prophylaxis to Eliminate Vertical Transmission of HIV

enthalten in: Global health, science and practice | 2023

von Ruel, T. | Penazzato, M. | Zech, J. | +13

10

Extended Analysis of HIV Infection in Cisgender Men and Transgender Women Who Have Sex with Men Receiving Injectable Cabotegravir for HIV Prevention : HPTN 083

enthalten in: Antimicrobial agents and chemotherapy | 2023

von Marzinke, M. | Fogel, J. | Wang, Z. | +26

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[20]